Related Experiment Video
Updated: Oct 5, 2026

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1
Abstract:
The phosphatidylinositol 3-kinase (PI3K) signaling pathway has inherent oncogenic potential. It is up-regulated in diverse human cancers by either a gain of function in PI3K itself or in its downstream target Akt or by a loss of function in the negative regulator PTEN. However, the complete consequences of this up-regulation are not known. Here we show that insulin and epidermal growth factor or an inactivating mutation in the tumor suppressor PTEN specifically increase the protein levels of hypoxia-inducible factor (HIF) 1alpha but not of HIF-1beta in human cancer cell lines. This specific elevation of HIF-1alpha protein expression requires PI3K signaling. In the prostate carcinoma-derived cell lines PC-3 and DU145, insulin- and epidermal growth factor-induced expression of HIF-1alpha was inhibited by the PI3K-specific inhibitors LY294002 and wortmannin in a dose-dependent manner. HIF-1beta expression was not affected by these inhibitors. Introduction of wild-type PTEN into the PTEN-negative PC-3 cell line specifically inhibited the expression of HIF-1alpha but not that of HIF-1beta. In contrast to the HIF-1alpha protein, the level of HIF-1alpha mRNA was not significantly affected by PI3K signaling. Vascular endothelial growth factor reporter gene activity was induced by insulin in PC-3 cells and was inhibited by the PI3K inhibitor LY294002 and by the coexpression of a HIF-1 dominant negative construct. Vascular endothelial growth factor reporter gene activity was also inhibited by expression of a dominant negative PI3K construct and by the tumor suppressor PTEN.
Insights
The phosphatidylinositol 3-kinase (PI3K) pathway upregulates hypoxia-inducible factor-1alpha (HIF-1alpha) protein, not mRNA, in cancer cells. This PI3K-dependent increase in HIF-1alpha is linked to cancer growth and can be targeted.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The phosphatidylinositol 3-kinase (PI3K) pathway is frequently dysregulated in human cancers.
- Up-regulation of PI3K signaling can occur through mutations in PI3K, Akt, or loss of the tumor suppressor PTEN.
- The full impact of PI3K pathway activation on cancer biology remains incompletely understood.
Purpose of the Study:
- To investigate the relationship between PI3K signaling and hypoxia-inducible factor (HIF) expression in cancer cells.
- To determine whether PI3K pathway activation specifically affects HIF-1alpha protein or mRNA levels.
- To explore the role of PI3K signaling in regulating vascular endothelial growth factor (VEGF) expression.
Main Methods:
- Utilized human cancer cell lines (PC-3, DU145) with varying PI3K pathway activity.
- Administered growth factors (insulin, epidermal growth factor) and PI3K inhibitors (LY294002, wortmannin).
- Assessed protein and mRNA levels of HIF-1alpha and HIF-1beta using Western blotting and other molecular techniques.
- Employed reporter gene assays to measure vascular endothelial growth factor (VEGF) activity.
Main Results:
- PI3K signaling, stimulated by insulin or EGF, specifically increased HIF-1alpha protein levels, but not HIF-1beta.
- PI3K inhibitors LY294002 and wortmannin dose-dependently blocked this increase in HIF-1alpha.
- Restoration of PTEN in PTEN-deficient cells reduced HIF-1alpha protein levels.
- PI3K activation did not significantly alter HIF-1alpha mRNA levels.
- Insulin-induced VEGF reporter gene activity was dependent on PI3K signaling and HIF-1 activity.
Conclusions:
- PI3K signaling pathway activation is a key regulator of HIF-1alpha protein stability in cancer cells.
- This regulation occurs post-transcriptionally, affecting protein levels rather than mRNA.
- Targeting the PI3K pathway may offer a strategy to inhibit HIF-1alpha and downstream targets like VEGF in cancer therapy.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

